1. Home
  2. BOLD vs RFIL Comparison

BOLD vs RFIL Comparison

Compare BOLD & RFIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BOLD
  • RFIL
  • Stock Information
  • Founded
  • BOLD 2018
  • RFIL 1979
  • Country
  • BOLD United States
  • RFIL United States
  • Employees
  • BOLD N/A
  • RFIL N/A
  • Industry
  • BOLD
  • RFIL Electrical Products
  • Sector
  • BOLD
  • RFIL Technology
  • Exchange
  • BOLD Nasdaq
  • RFIL Nasdaq
  • Market Cap
  • BOLD 30.3M
  • RFIL 39.9M
  • IPO Year
  • BOLD 2024
  • RFIL N/A
  • Fundamental
  • Price
  • BOLD $1.50
  • RFIL $3.97
  • Analyst Decision
  • BOLD Hold
  • RFIL Strong Buy
  • Analyst Count
  • BOLD 1
  • RFIL 1
  • Target Price
  • BOLD N/A
  • RFIL $4.50
  • AVG Volume (30 Days)
  • BOLD 63.1K
  • RFIL 20.1K
  • Earning Date
  • BOLD 05-16-2025
  • RFIL 06-12-2025
  • Dividend Yield
  • BOLD N/A
  • RFIL N/A
  • EPS Growth
  • BOLD N/A
  • RFIL N/A
  • EPS
  • BOLD N/A
  • RFIL N/A
  • Revenue
  • BOLD N/A
  • RFIL $70,599,000.00
  • Revenue This Year
  • BOLD N/A
  • RFIL $16.16
  • Revenue Next Year
  • BOLD N/A
  • RFIL $5.75
  • P/E Ratio
  • BOLD N/A
  • RFIL N/A
  • Revenue Growth
  • BOLD N/A
  • RFIL 4.93
  • 52 Week Low
  • BOLD $1.06
  • RFIL $2.88
  • 52 Week High
  • BOLD $12.26
  • RFIL $5.77
  • Technical
  • Relative Strength Index (RSI)
  • BOLD N/A
  • RFIL 47.67
  • Support Level
  • BOLD N/A
  • RFIL $3.76
  • Resistance Level
  • BOLD N/A
  • RFIL $4.11
  • Average True Range (ATR)
  • BOLD 0.00
  • RFIL 0.19
  • MACD
  • BOLD 0.00
  • RFIL 0.03
  • Stochastic Oscillator
  • BOLD 0.00
  • RFIL 61.11

About BOLD Boundless Bio Inc. Common Stock

Boundless Bio Inc is a clinical-stage oncology company. The company is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.

About RFIL RF Industries Ltd.

RF Industries Ltd is engaged in the design, manufacture, and marketing of interconnect products and systems, including coaxial and specialty cables, fiber optic cables and connectors, and electrical and electronic specialty cables. The company operates through two segments: RF Connector and Cable Assembly, which consists of the Connector and Cable Assembly Division, and Custom Cabling Manufacturing and Assembly, which consists of its subsidiaries. The company has operations in the United States, Canada, Israel, and Mexico.

Share on Social Networks: